Home Search

vaccine - search results

If you're not happy with the results, please do another search
This landmark trial aims to evaluate the efficacy of DengiAll, India’s indigenous tetravalent dengue vaccine developed by Panacea Biotec

Breakthrough: India starts Phase 3 trial for tetravalent dengue vaccine

PGurus Newsdesk - 0
India’s DengiAll vaccine enters crucial Phase 3 testing In a groundbreaking development, the Indian Council of Medical Research (ICMR) and Panacea Biotec announced on Wednesday...
The vaccine maker indicated that the global withdrawal was started for commercial reasons

AstraZeneca withdraws COVID-19 vaccine globally, cites ‘commercial reason’

PGurus Newsdesk - 0
Know why AstraZeneca recalled COVID-19 vaccine AstraZeneca has announced that it will withdraw its COVID-19 vaccine globally. This comes days after it was revealed that...
Several families filed complaints in court alleging that the AstraZeneca vaccine’s side-effects have had devastating effects

AstraZeneca admits its COVID vaccine can cause side effect called TTS in rare cases

PGurus Newsdesk - 1
In a first, AstraZeneca admits its Covid vaccine Covishield can cause rare side effects For the first time, AstraZeneca has admitted in court documents that...
“The Vaccine War” is not just a cinematic triumph; it is a celebration of Bharatiya cinema’s ability to touch the hearts and souls of audiences worldwide

The Vaccine War: An antidote to Urduwood cinema

JK - 0
The Vaccine War - A masterpiece that demands recognition and applause In the vast tapestry of Indian cinema, there exists a potent thread known as...
The current prototype can produce 100 patches in 48 hours, but the researchers anticipate that future versions could be designed to have higher capacity

US researchers develop mobile vaccine printer; eliminates need for injection

PGurus Newsdesk - 0
Afraid need for injection; you may soon get vaccines via skin patches Researchers at the Massachusetts Institute of Technology (MIT) in the US have developed...
Made-in-India intranasal Covid vaccine to be launched on R-Day

First ‘Made-in-India’ intranasal Covid vaccine to be launched by Bharat Biotech on R-Day

PGurus Newsdesk - 1
Bharat Biotech to launch intranasal Coronavirus vaccine 'iNCOVACC' on Republic Day Bharat Biotech will launch its intranasal COVID-19 vaccine 'iNCOVACC' on January 26, the company's...
The nasal vaccine has been approved for those aged above 18 years. The vaccine will be available in private hospitals for a booster dose in the initial phase

Bharat Biotech’s needle-free intranasal Covid vaccine approved as booster dose

PGurus Newsdesk - 2
The intranasal Covid vaccine to be introduced in the COVID-19 vaccination program from today The Centre on Friday approved Bharat Biotech's needle-free intranasal Covid vaccine...
PCV14 may be administered to infants 6, 10, and 14 weeks of age in 3 doses

DCGI clears Biological E’s 14-valent pneumococcal conjugate vaccine

PGurus Newsdesk - 0
Drugs regulator approves BE-PCV14 vaccine to protect infants against Streptococcus pneumoniae infection Biological E. Limited (BE), a Hyderabad-based Pharmaceutical and Vaccine Company Friday announced that...
India ranks third worldwide for production by volume and 14th by value

Pharma exports grow 103% in 8 yrs; 60% world’s vaccines, 20% generic drugs come...

PGurus Newsdesk - 0
India's pharma exports hit Rs.1.83 lakh cr in 2021-22 On Sunday the commerce ministry said that the Indian pharma sector logged a 103 percent rise...
Government of Japan includes the indigenously developed and manufactured COVID-19 vaccine Covaxin

Japan includes India’s Covaxin in the list of recognized vaccines to facilitate travel from...

PGurus Newsdesk - 0
Japan recognizes India's Covaxin with effect from 10 April Japan recognizes India's COVID-19 vaccine Covaxin manufactured by Bharat Biotech with effect from 10 April to...
123...39Page 1 of 39

BOOKS